Real World Experience with Maribavir for the Treatment of Cytomegalovirus in Solid Organ Transplant Recipients

被引：0
|
作者：
Sabatino, D. [1 ]
Hedvat, J. [1 ]
Salerno, D. M. [1 ]
Pereira, M. [2 ]
Lange, N. W. [3 ]
机构：
[1] NewYork Presbyterian Hosp, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
[3] NewYork Presbyterian Hosp, Pharm, New York, NY USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D128
引用
收藏
页码：S1117 / S1117
页数：1
相关论文
共 50 条
  • [41] RECURRENT CYTOMEGALOVIRUS DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS
    FALAGAS, ME
    SNYDMAN, DR
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 34 - 37
  • [42] Indirect effects of cytomegalovirus infection in solid organ transplant recipients
    Perez-Sola, Maria Jose
    Caston, Juan Jose
    Solana, Rafael
    Rivero, Antonio
    Torre-Cisneros, Julian
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (01): : 38 - 47
  • [43] Management of cytomegalovirus infection in solid-organ transplant recipients
    Murray, BM
    IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (1-2) : 243 - 255
  • [44] Etiology and impact of cytomegalovirus disease on solid organ transplant recipients
    McDevitt, Lisa M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S3 - S9
  • [45] Gastrointestinal infections due to cytomegalovirus in solid organ transplant recipients
    Azap, Ozlem Kurt
    Senger, Suheyla Serin
    Timurkaynak, Funda
    Kursun, Ebru
    Arslan, Hande
    Demirhan, Beyhan
    Haberal, Mehmet
    TRANSPLANT INTERNATIONAL, 2007, 20 : 198 - 198
  • [46] Cytomegalovirus (CMV) Prevention in Pediatric Solid Organ Transplant Recipients
    Suresh, S.
    Lee, B.
    Robinson, J.
    Akinwumi, M.
    Preiksaitis, J.
    TRANSPLANTATION, 2014, 98 : 236 - 237
  • [47] EXPERIENCE WITH THE USE OF MARIBAVIR IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS WITH REFRACTORY OR RESISTANT CYTOMEGALOVIRUS (CMV)
    Fernandez Perez, Monica
    Ceballos Bolanos, Candela
    Oiartzabal Ormategui, Itziar
    Arratibel Zalacain, Nerea
    Millacoy Austenrritt, Pamela
    Aranguren Ostolaza, Marina
    Viguria Alegria, Maria Cruz
    Panizo Santos, Carlos Manuel
    BONE MARROW TRANSPLANTATION, 2024, 59 : 475 - 476
  • [48] Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: Markers of Inflammation as Predictors of Outcome
    Rollag, Halvor
    Asberg, Anders
    Ueland, Thor
    Hartmann, Anders
    Jardine, Alan G.
    Humar, Atul
    Pescovitz, Mark D.
    Bignamini, Angelo A.
    Aukrust, Pal
    TRANSPLANTATION, 2012, 94 (10) : 1060 - 1065
  • [49] Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients
    Fishman, JA
    Doran, MT
    Volpicelli, SA
    Cosimi, AB
    Flood, JG
    Rubin, RH
    TRANSPLANTATION, 2000, 69 (03) : 389 - 394
  • [50] Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients
    Linder, Kathleen A.
    Kovacs, Christopher
    Mullane, Kate M.
    Wolfe, Cameron
    Clark, Nina M.
    La Hoz, Ricardo M.
    Smith, Jeannina
    Kotton, Camille N.
    Limaye, Ajit P.
    Malinis, Maricar
    Hakki, Morgan
    Mishkin, Aaron
    Gonzalez, Arnoldo Adrian
    Prono, Maria Dioverti
    Ostrander, Darin
    Avery, Robin
    Kaul, Daniel R.
    TRANSPLANT INFECTIOUS DISEASE, 2021,
12345